Results 291 to 300 of about 141,025 (360)

Proteins and signalling pathways targeted by dapagliflozin and finerenone: Insights from DAPA‐CKD and FIGARO‐DKD

open access: yes
Diabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 750-753, January 2026.
Mark André de la Rambelje   +4 more
wiley   +1 more source

Dietary flavanols preserve upper‐ and lower‐limb endothelial function during sitting in high‐ and low‐fit young healthy males

open access: yesThe Journal of Physiology, Volume 604, Issue 1, Page 145-171, 1 January 2026.
Abstract figure legend Schematic indicating the design of an acute randomised, counterbalanced, double‐blinded, cross‐over, placebo‐controlled human study in which 20 high‐fit males and 20 low‐fit males consumed either a low‐flavanol (5.6 mg) or a high‐flavanol (695 mg) cocoa drink prior to a 2 h uninterrupted sitting bout.
Alessio Daniele   +2 more
wiley   +1 more source

Cardiovascular Dysfunction in Polycystic Ovary Syndrome: Mitochondrial and Inflammatory Mechanisms

open access: yesBioMed Research International, Volume 2026, Issue 1, 2026.
Background Polycystic ovary syndrome (PCOS) is a common endocrine disorder that significantly increases cardiovascular disease (CVD) risk in women. While insulin resistance and dyslipidemia are established contributors, growing evidence highlights mitochondrial dysfunction and chronic low‐grade inflammation as central drivers of cardiovascular ...
Olabimpe Caroline Badejogbin   +8 more
wiley   +1 more source

Ultrastructural Analysis of the Saphenous Vein Endothelium in a Patient With Proinflammatory Comorbidities Undergoing Coronary Artery Bypass Grafting

open access: yesCase Reports in Medicine, Volume 2026, Issue 1, 2026.
The saphenous vein (SV) remains one of the most widely used grafts in coronary artery bypass grafting (CABG), and the integrity of the endothelium—a complex structure susceptible to deleterious effects from proinflammatory comorbidities—is a critical factor for graft patency. A 75‐year‐old patient with hypertension, dyslipidemia, insulin‐dependent Type
Matheus Duarte Pimentel   +3 more
wiley   +1 more source

The Use of Tranexamic Acid to Treat Melasma: A Systematic Review and Meta‐Analysis

open access: yesDermatologic Therapy, Volume 2026, Issue 1, 2026.
Introduction Tranexamic acid (TXA) is a synthetic derivative of the amino acid lysine that inhibits bleeding due to its effects on plasminogen conversion, approved by the FDA to treat menorrhagia and prevent bleeding in hemophilia patients undergoing dental extraction.
Nabila Scabine Pessotti   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy